Although marijuana still is a Schedule I narcotic, the Food and Drug Administration (FDA) generally limits its concerns to safety and efficacy. Epidiolex hit both marks during clinical trials underpinning its application, which makes an approval seem likely. The FDA accepted Epidiolex's application for ...

Read more